Significant mitral regurgitation in patients undergoing TAVR: Mechanisms and imaging variables associated with improvement

Background Significant mitral regurgitation (MR) is associated with poorer outcomes in patients undergoing transcatheter aortic valve replacement (TAVR). Factors associated with MR improvement have not been studied thoroughly. Methods Retrospective analysis of consecutive patients treated with TAVR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Echocardiography (Mount Kisco, N.Y.) N.Y.), 2019-04, Vol.36 (4), p.722-731
Hauptverfasser: Chiche, Olivier, Rodés‐Cabau, Josep, Campelo‐Parada, Francisco, Freitas‐Ferraz, Afonso B., Regueiro, Ander, Chamandi, Chekrallah, Rodriguez‐Gabella, Tania, Côté, Mélanie, DeLarochellière, Robert, Paradis, Jean‐Michel, Dumont, Eric, Doyle, Daniel, Mohammadi, Siamak, Bergeron, Sébastien, Pibarot, Philippe, Beaudoin, Jonathan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Significant mitral regurgitation (MR) is associated with poorer outcomes in patients undergoing transcatheter aortic valve replacement (TAVR). Factors associated with MR improvement have not been studied thoroughly. Methods Retrospective analysis of consecutive patients treated with TAVR with more than mild MR at baseline. MR evolution was assessed at 1–3 and 6–12 months after intervention. MR severity and mechanisms were assessed by echocardiography. Mitral annulus calcification (MAC) was quantified using preoperative cardiac CT. Results From 674 consecutive TAVR recipients, 78 with more than mild MR had a 6–12 months follow‐up. Following TAVR, MR improved in 34 patients (43%), remained stable in 38 (49%) and worsened in 6 (8%). Patients with MR improvement had greater tenting area (141 ± 56 vs. 99 ± 40 mm2, P 
ISSN:0742-2822
1540-8175
DOI:10.1111/echo.14303